{
    "text": "Taken together, our study indicate variable expression and clinical role of B7-family ligands in SCLC with predominant expression of the candidate target B7-H3 and the presence of a limited cytotoxic anti-tumor immune response.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "B7", 
            "span": {
                "begin": 76, 
                "end": 78
            }
        }, 
        {
            "id": "T2", 
            "obj": "disease", 
            "span": {
                "begin": 97, 
                "end": 101
            }
        }
    ], 
    "relations": [
        {
            "id": "R1", 
            "pred": "therapeutic", 
            "subj": "T2", 
            "obj": "T1"
        }
    ]
}